Clinical Trial Update: A Trial of Endostar in Patients With Carcinoma of the Head and Neck [Phase 2]

View source ↗

Summary

This document notes a Phase 2 trial evaluating Endostar (recombinant human endostatin) in patients with nasopharyngeal neoplasms, with the trial status listed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Neoplasms

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: China International Medical Foundation | Conditions: Nasopharyngeal Neoplasms | Phase 2 | Status: UNKNOWN